Plain-English translation of NCT07614230 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Phase
Post-approval monitoring
Sponsor
Junjie Yang
Enrollment target
~144 participants
Started
January 2026
Primary completion
June 2027
Age range
18 Years – 78 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Junjie Yang, MD
Junjie Yang
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.